-+ 0.00%
-+ 0.00%
-+ 0.00%

EDGEWISE THERAPEUTICS INC - PHASE 2 OBSERVATIONS IN DUCHENNE DEFINE DOSE FOR PHASE 3

Reuters·06/26/2025 10:00:19

Please log in to view news